XML 14 R7.htm IDEA: XBRL DOCUMENT v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
OPERATING ACTIVITIES:    
Net income (loss) $ 264,000 $ (1,439,000)
Adjustments to reconcile net income (loss) to cash provided by (used in) operating activities:    
Depreciation and amortization 803,000 832,000
Bad debt expense (6,000) 0
Interest amortization of deferred financing costs 24,000 24,000
Stock-based compensation expense 750,000 895,000
Deferred income taxes, net 637,000 3,000
Operating lease assets and liabilities, net 20,000 15,000
Amortization of deferred compensation 125,000 125,000
Unrealized FX on monetary items (102,000) 73,000
Working capital items:    
Accounts receivable and unbilled receivables (1,313,000) (703,000)
Prepaid and other current assets 210,000 (127,000)
Accounts payable (78,000) (942,000)
Accrued payroll and related costs (4,452,000) (1,729,000)
Other accrued liabilities (217,000) 162,000
Deferred revenue 173,000 (111,000)
Net cash flows provided by (used in) operating activities (3,162,000) (2,922,000)
INVESTING ACTIVITIES:    
Recovery of (payment for) non-current deposits (15,000) (19,000)
Capital expenditures (66,000) (114,000)
Net cash flows (used in) investing activities (81,000) (133,000)
FINANCING ACTIVITIES:    
Proceeds from the issuance of common shares 3,000 0
Proceeds from the exercise of stock options 681,000 27,000
Net cash flows provided by (used in) financing activities 684,000 27,000
Effect of exchange rate changes on cash and cash equivalents (424,000) (49,000)
Net change in cash and cash equivalents (2,983,000) (3,077,000)
Cash and cash equivalents, beginning of period 36,533,000 27,742,000
Cash and cash equivalents, end of period $ 33,550,000 $ 24,665,000